Skip to main content
GlaxoSmithKline PLC logo

GlaxoSmithKline PLC — Investor Relations & Filings

Ticker · GSK ISIN · GB00BN7SWP63 LEI · 5493000HZTVUYLO1D793 IL Manufacturing
Open in API
Filings indexed 7,025 across all filing types
Latest filing 2025-07-23 Regulatory Filings
Country GB United Kingdom
Listing IL GSK

About GlaxoSmithKline PLC

https://www.gsk.com/en-gb/

GSK plc is a global biopharmaceutical company that unites science, technology, and talent to research, develop, and manufacture medicines and vaccines. The company focuses on preventing and treating disease across four primary therapeutic areas: infectious diseases, HIV, oncology, and immunology/respiratory. Its portfolio consists of specialty medicines and vaccines aimed at addressing significant global health needs. GSK's strategy centers on leveraging its research and development capabilities to deliver new health solutions.

Recent filings

Filing Released Lang Actions
US FDA REVIEW EXTENDED FOR BLENREP
Regulatory Filings
2025-07-23 English
TRANSACTION IN OWN SHARES
Regulatory Filings
2025-07-23 English
US FDA review extended for Blenrep
Regulatory Filings Classification · 98% confidence The document is a regulatory announcement (RNS) from GSK PLC regarding the extension of an FDA review period for a drug (Blenrep). It follows the standard format of a corporate press release/regulatory announcement, providing details on clinical trial results (DREAMM-7 and DREAMM-8) and regulatory status. It does not fit into specific categories like financial reports, board changes, or shareholder voting results. As it is a general regulatory announcement regarding company operations and product development, it falls under the RNS category.
2025-07-23 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is an official announcement from GSK plc regarding the purchase of its own shares (share buyback) on the London Stock Exchange. It includes specific details such as the number of shares purchased, price paid, and the impact on treasury shares and total voting rights. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS).
2025-07-23 English
TRANSACTION IN OWN SHARES
Regulatory Filings
2025-07-22 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document text explicitly states it is an announcement regarding a 'Transaction in own shares' by GSK plc. It details the date of purchase (21 July 2025), the number of shares purchased (504,228), the price range, and confirms the shares will be held as Treasury shares as part of an existing buyback programme. This directly matches the definition for 'Transaction in Own Shares' (POS), which covers company share repurchase/issuance activities.
2025-07-22 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.